Brooklyn Investment Group’s SpringWorks Therapeutics SWTX Stock Holding History

Brooklyn Investment Group’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-28	Closed	-$1.32K	–	2444
2025 Q2	$1.32K	Buy	28 +18	+180%	+$801	﹤0.01%	2864
2025 Q1	$442	Buy	+10	New	+$460	﹤0.01%	2509

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brooklyn Investment Group's SWTX Position: Q3 2025 in Review

Brooklyn Investment Group sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 28 shares — an estimated $1.32K sold.

Brooklyn Investment Group first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $1.32K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Brooklyn Investment Group reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Brooklyn Investment Group sold 28 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.32K.
Brooklyn Investment Group first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Brooklyn Investment Group's SpringWorks Therapeutics position peaked at $1.32K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.